Cargando…
Booster COVID-19 Vaccines for Immune-Mediated Inflammatory Disease Patients: A Systematic Review and Meta-Analysis of Efficacy and Safety
Background: Seroconversion and longevity of vaccine-induced immune response is blunted in immune-mediated inflammatory disease (IMID) patients owing to immunosuppressive regimens. COVID-19 booster vaccines after a primary series have been proposed with inconclusive evidence on efficacy to date. Meth...
Autores principales: | Lee, Ainsley Ryan Yan Bin, Wong, Shi Yin, Tay, Sen Hee |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9144569/ https://www.ncbi.nlm.nih.gov/pubmed/35632424 http://dx.doi.org/10.3390/vaccines10050668 |
Ejemplares similares
-
Efficacy of covid-19 vaccines in immunocompromised patients: systematic review and meta-analysis
por: Lee, Ainsley Ryan Yan Bin, et al.
Publicado: (2022) -
Booster doses of COVID-19 vaccines for patients with haematological and solid cancer: a systematic review and individual patient data meta-analysis
por: Mai, Aaron Shengting, et al.
Publicado: (2022) -
Evaluation of the Efficacy of COVID-19 Booster Vaccinations in Healthcare Personnel
por: Kim, Chung-Jong, et al.
Publicado: (2022) -
COVID-19 vaccine safety and efficacy in patients with immune-mediated inflammatory disease: Review of available evidence
por: Wack, Sarah, et al.
Publicado: (2021) -
Risk of Absence of Measles Antibody in Healthcare Personnel and Efficacy of Booster Vaccination
por: Kim, Chung-Jong, et al.
Publicado: (2021)